Approximately 3–7% (more than 60,000 cases annually) of NSCLC patients involve ALK gene rearrangements, more frequently found in adenocarcinoma cases and non-smokers or light smokers [5,6,7]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.